Oncology Inc. (NASDAQ:ZIOP) earlier this week, Jonathan Lewis, M.D., Ph.D., Chief Executive Officer, and Francois Lebel, M.D., Senior Vice President, Clinical Development and Medical Operations, presented at the 16th Annual BIO CEO & Investor Conference. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) stock opened at $4.50 in last session, and closed at $4.33, while the day range of ZIOP stock is $4.30-4.57.The stock showed a positive weekly performance of 7.44%.
Celgene Corporation (NASDAQ:CELG), discovers, develops and commercializes therapies for cancer and immune-inflammatory related diseases in the US and Europe. It has strategic collaborations with bluebird bio, FORMA Therapeutics, Concert Pharmaceuticals, Array BioPharma, Acetylon Pharmaceuticals, PharmAkea Therapeutics, and a strategic alliance with MorphoSys AG. Celgene Corporation (NASDAQ:CELG) stock opened at $165.42, in last session and closed at $163.93, by loosed -0.49%.The 52 week range of $97.85-174.66.Company’s market capitalization is $67.55 billion.
AbbVie Inc (NYSE:ABBV) Sovaldi is not without competition as the FDA also approved Johnson & Johnson’s (NYSE:JNJ) oral hepatitis C pill Olysio a month earlier, and AbbVie (NYSE: ABBV), in December, reported impressive results in a late-stage trial of its all-oral regimen for hepatitis C. AbbVie Inc (NYSE:ABBV) stock gained 0.75% and finished the last session at $50.73.The EPS of the stock remained 2.57.Company’s market capitalization is $80.55 billion.
Vertex Pharmaceuticals (VRTX) has been upgraded by TheStreet Ratings from sell to hold. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and feeble growth in the company’s earnings per share.,” the firm’s analyst wrote. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stock opened the session at $84.38, and closed the session at $81.61. The 52 week range of the VTRX stock remained $43.69-89.96 and the day range was $81.05 – $84.98.